TickerFacts.

Delcath Systems, Inc. (DCTH): Revenue

Annual figures by period end, from SEC filings.

$85.23M
Year ended 2025-12-31
$95.42M
Trailing 12 months to 2026-06-30
+215.3%
3-year compound annual growth
2021-12-31: $3.56M2022-12-31: $2.72M2023-12-31: $2.06M2024-12-31: $37.20M2025-12-31: $85.23M$85.23M
2021-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$85.23M+129.1%2026-02-26, From 2025-01-01
2024-12-31$37.20Mn/m2026-02-26, From 2024-01-01
2023-12-31$2.06M-24.1%2025-03-06, From 2023-01-01
2022-12-31$2.72M-23.5%2024-03-26, From 2022-01-01
2021-12-31$3.56Mn/a2023-03-27, From 2021-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Delcath Systems, Inc. (DCTH)2025-12-31$85.23M+129.1%
Iradimed Corp (IRMD)2025-12-31$83.81M+14.4%
TELA Bio, Inc. (TELA)2025-12-31$80.28M+15.8%
Pulmonx Corp (LUNG)2025-12-31$90.50M+8.0%
PRO DEX Inc (PDEX)2026-06-30$77.55M+16.5%
Sight Sciences, Inc. (SGHT)2025-12-31$77.36M-3.1%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$95.13M+59.0%
NeuroPace Inc (NPCE)2025-12-31$99.99M+25.1%
Beta Bionics, Inc. (BBNX)2025-12-31$100.25M+53.9%

Compare DCTH, IRMD, TELA, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗